GERMANY - Gilde Healthcare Partners co-leads EUR 7m mtm funding

Return backers include HBM BioVentures, HBM BioCapital, Wellington Partners, Mannheim Holdings, Heidelberg Innovation and Nexus Medical Partners. This new tranche expands the company's C-round to EUR 39m.

Based in Heidelberg, mtm develops and manufacturs of in-vitro diagnostic devices for use in the early detection and diagnosis of cervical cancer. The company operates subsidiaries in the United States, France, Italy and Spain.

mtm plans to use the proceeds of this financing to expand its clinical development activities and to bolster its commercialization efforts, specifically on the company's IVD products.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH